These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37261506)

  • 1. Histological and immunohistochemical prognostic factors of primary angiosarcoma.
    Ichiki T; Yamada Y; Ito T; Nakahara T; Nakashima Y; Nakamura M; Yoshizumi T; Shiose A; Akashi K; Oda Y
    Virchows Arch; 2023 Jul; 483(1):59-69. PubMed ID: 37261506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
    Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
    J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
    Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
    J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
    Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
    Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
    Jour G; Gullet A; Liu M; Hoch BL
    Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
    Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
    J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.
    Cornejo KM; Hutchinson L; Cyr MS; Nose V; McLaughlin PJ; Iafrate AJ; Sadow PM
    Endocr Pathol; 2015 Dec; 26(4):334-41. PubMed ID: 26223194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
    Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
    J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Primary Angiosarcoma: A Clinicopathologic and Imaging Study of a Series Cases.
    Darre T; Djiwa T; N'Timon B; Simgban P; Tchaou M; Napo-Koura G
    Breast Cancer (Auckl); 2022; 16():11782234221086726. PubMed ID: 35370408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Epithelioid Angiosarcoma of the Submandibular Gland-A Case Report with Histology-Cytology Correlation and Comprehensive Molecular Analysis.
    Oon ML; Wu B; Goh JY; Chang KTE; Chong YL; Wong ZW; Oh SY; Tan C; Nga ME; Petersson F
    Head Neck Pathol; 2024 Jun; 18(1):56. PubMed ID: 38916683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic cutaneous angiosarcomas generally lack hypoxia-inducible factor 1alpha: a histologic and immunohistochemical study of 45 cases.
    Abedalthagafi M; Rushing EJ; Auerbach A; Desouki MM; Marwaha J; Wang Z; Fanburg-Smith JC
    Ann Diagn Pathol; 2010 Feb; 14(1):15-22. PubMed ID: 20123452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiosarcoma of the visceral organs: A morphological, immunohistochemical, and C-MYC status analysis.
    Zhang J; Gong H; Wang Y; Zhang G; Hou P
    Pathol Res Pract; 2022 Oct; 238():154118. PubMed ID: 36087414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
    Hasegawa T; Yokoyama R; Lee YH; Shimoda T; Beppu Y; Hirohashi S
    Oncology; 2000; 58(1):66-74. PubMed ID: 10644943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
    Shon W; Jenkins SM; Ross DT; Seitz RS; Beck RA; Ring BZ; Okuno SH; Gibson LE; Folpe AL
    J Cutan Pathol; 2011 Dec; 38(12):961-6. PubMed ID: 22050093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasculogenic Mesenchymal Tumor: A Clinicopathologic and Molecular Study of 55 Cases of a Distinctive Neoplasm Originating From Mediastinal Yolk Sac Tumor and an Occasional Precursor to Angiosarcoma.
    Levy DR; Agaram NP; Kao CS; Franks SE; Kesler KA; Stram AR; Einhorn LH; Bangs CD; Ulbright TM
    Am J Surg Pathol; 2021 Apr; 45(4):463-476. PubMed ID: 33136584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.